Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products
The data presented in this article are related to the research article “Intramyocardial Fate and Effect of Iron Nanoparticles co-injected with MACS® purified Stem Cell Products” (Müller et al., 2017) [1]. This article complements the cellular localization of superparamagnetic iron dextran particles...
Main Authors: | Paula Müller, Ralf Gaebel, Heiko Lemcke, Gustav Steinhoff, Robert David |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340917302792 |
Similar Items
-
Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
by: Christian Klopsch, et al.
Published: (2018-06-01) -
Successful subretinal delivery and monitoring of MicroBeads in mice.
by: M Dominik Fischer, et al.
Published: (2013-01-01) -
Angiogenic Potential of Bone Marrow Derived CD133<sup>+</sup> and CD271<sup>+</sup> Intramyocardial Stem Cell Trans- Plantation Post MI
by: Sarah Sasse, et al.
Published: (2019-12-01) -
Safety of Intramyocardial Stem Cell Therapy for the Ischemic Myocardium: Results of the Rostock Trial after 5-Year Follow-Up
by: Can Yerebakan, et al.
Published: (2007-10-01) -
Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells
by: Paula Müller, et al.
Published: (2016-01-01)